MSI Financial Services’s Standard BioTools LAB Stock Holding History

MSI Financial Services’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$0	Hold	3	–	–	﹤0.01%	3914
2016 Q3	$0	Hold	3	–	–	﹤0.01%	3946
2016 Q2	$0	Sell	3 -1	-25%	-$9	﹤0.01%	4010
2016 Q1	$0	Sell	4 -7	-64%	-$50	﹤0.01%	4024
2015 Q4	$0	Sell	11 -4	-27%	-$39	﹤0.01%	3913
2015 Q3	$0	Sell	15 -488	-97%	-$7.68K	﹤0.01%	3269
2015 Q2	$12K	Buy	503 +502	+50,200%	+$15.8K	﹤0.01%	2039
2015 Q1	$0	Buy	+1	New	+$40	﹤0.01%	3079

Other funds holding LAB

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MSI Financial Services's LAB Position: Q4 2016 in Review

MSI Financial Services held its Standard BioTools (LAB) position steady in Q4 2016 at 3 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3914.

MSI Financial Services first reported a position in LAB in Q1 2015 and has held it in 8 quarters since. The position peaked at $12K in Q2 2015. 83 funds tracked by Wall St. Rank hold LAB as of Q4 2016.

MSI Financial Services held 3 shares of Standard BioTools worth $0 as of Q4 2016.
MSI Financial Services left its Standard BioTools share count unchanged in Q4 2016.
Standard BioTools made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3914 holding.
MSI Financial Services first reported a position in Standard BioTools in Q1 2015 and has held it in 8 quarters since.
MSI Financial Services's Standard BioTools position peaked at $12K in Q2 2015.
83 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.